SCPL - SciPlay gains as upgraded to Buy from Hold at Truist

Truist analyst Matthew Thornton upgraded SciPlay (SCPL +4.9%) to Buy from Hold with a price target of $15, up from $14. The analyst sees a more favorable risk reward on the stock, with valuation turning "attractive" and board additions that bring in "valuable experience". Thornton further cites multiple fundamental "shots on goal" for SciPlay with Alictus, Project X, Solitaire, DTC platform, and Project All-Star, along with its "event shots on goal" with Investor Day and Playtika strategic review. Since the start of 2022, SciPlay shares fell around 4%, and over a period of one year, shares were down around 19%. Wall Street analysts stand with a Buy rating on the stock whereas, Seeking Alpha Quant Rating say to Hold.

For further details see:

SciPlay gains as upgraded to Buy from Hold at Truist